Skip to main content

EDITORIAL article

Front. Immunol.
Sec. Molecular Innate Immunity
Volume 15 - 2024 | doi: 10.3389/fimmu.2024.1472727
This article is part of the Research Topic Bringing Function to the Forefront of Cell Therapy: How Do We Demonstrate Potency? View all 7 articles

Editorial: Bringing Function to the Forefront of Cell Therapy: How Do We Demonstrate Potency?

Provisionally accepted
Alasdair R. Fraser Alasdair R. Fraser 1*Stuart Curbishley Stuart Curbishley 2Andy Römhild Andy Römhild 3Kwong Tsang Kwong Tsang 4
  • 1 University of Glasgow, Glasgow, Scotland, United Kingdom
  • 2 University of Birmingham, Birmingham, England, United Kingdom
  • 3 Berlin Center for Advanced Therapies, Charité Medical University of Berlin, Berlin, Baden-Württemberg, Germany
  • 4 Precision Biologics, Inc., Rockville, Maryland, United States

The final, formatted version of the article will be published soon.

    Keywords: Potency, cell therapy, Assays, T cells, mesenchymal stem cell, NK cell

    Received: 29 Jul 2024; Accepted: 30 Jul 2024.

    Copyright: © 2024 Fraser, Curbishley, Römhild and Tsang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Alasdair R. Fraser, University of Glasgow, Glasgow, G12 8QQ, Scotland, United Kingdom

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.